Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4/6 Inhibition.
Leonard SchmiesterFara Brasó-MaristanyBlanca Gonzalez-FarreTomás PascualJoaquín GaviláXavier TekpliJürgen GeislerVessela N KristensenArnoldo FrigessiAleix PratAlvaro Köhn-LuquePublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
A mathematical modeling approach accurately predicts patient outcome following CDK4/6i plus endocrine therapy that marks a step toward more personalized treatments in patients with Luminal B breast cancer.